Literature DB >> 3280589

Endogenous dopamine (DA) and DA2 receptors: a mechanism limiting excessive sympathetic-adrenal discharge in humans.

M Mannelli1, C Pupilli, G Fabbri, R Musante, M L De Feo, F Franchi, G Giusti.   

Abstract

We studied the effects of presynaptic dopamine (DA) 2 receptor blockade on the sympathetic-adrenal response to graded exercise in seven normal men. DA2 receptor blockade was achieved by means of domperidone (DMP) administration. The exercise consisted of progressive cycling activity, from 30-80% of the predetermined maximal oxygen consumption for each man. Systolic, diastolic, and mean arterial pressures; heart rate; and plasma norepinephrine (NE), epinephrine (E), PRL, glucose, lactate, FFA, sodium, potassium, cortisol, and PRA were measured at rest, during exercise, and during recovery after placebo or DMP administration. Graded exercise caused significant increases in systolic and mean arterial pressures and plasma NE, E, lactate, sodium, potassium, FFA, cortisol, and PRA. DMP administration before exercise caused a significant increase in plasma PRL (P = 0.0009), a greater increase in plasma NE at the end of the exercise (P = 0.002), and an overall increase in plasma E (P = 0.02) and FFA (P = 0.02) concentrations. These results strongly suggest that endogenous DA limits catecholamine release during sympathetic-adrenal stimulation by activating DA2 receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280589     DOI: 10.1210/jcem-66-3-626

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Management of neurogenic orthostatic hypotension in patients with autonomic failure.

Authors:  Christoph Schroeder; Jens Jordan; Horacio Kaufmann
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

2.  Renal and neurohumoral effects of ibopamine and metoclopramide in normal man.

Authors:  A R Girbes; D J van Veldhuisen; A J Smit; A Drent-Bremer; S Meijer; W D Reitsma
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

3.  Veralipride-induced acute coronary syndrome unmasking a non-secreting pheochromocytoma.

Authors:  D Montemurro; G P Rossi
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

4.  Roles of dopaminergic d(1) and d(2) receptors in catecholamine release from the rat adrenal medulla.

Authors:  Young Joo Baek; Yoo Seong Seo; Dong Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2008-02-28       Impact factor: 2.016

Review 5.  Subclinical phaeochromocytoma.

Authors:  Massimo Mannelli; Jacques W M Lenders; Karel Pacak; Gabriele Parenti; Graeme Eisenhofer
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

6.  Are the effects of noradrenaline, adrenaline and dopamine infusions on VO2 and metabolism transient?

Authors:  H Ensinger; T Weichel; K H Lindner; A Grünert; M Georgieff
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440

Review 7.  The dopaminergic control of Cushing's syndrome.

Authors:  R Pivonello; C Pivonello; C Simeoli; M C De Martino; A Colao
Journal:  J Endocrinol Invest       Date:  2022-04-23       Impact factor: 5.467

8.  Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis.

Authors:  Giulio Scigliano; Gabriele Ronchetti
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

9.  Influence of Nicotine from Diverse Delivery Tools on the Autonomic Nervous and Hormonal Systems.

Authors:  Valerii A Menshov; Aleksei V Trofimov; Alla V Zagurskaya; Nadezda G Berdnikova; Olga I Yablonskaya; Anna G Platonova
Journal:  Biomedicines       Date:  2022-01-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.